<DOC>
	<DOC>NCT00042666</DOC>
	<brief_summary>This study will measure the effectiveness and any side effects of LY317615 in patients with Diffuse large B-cell lymphoma (a sub-type of Non-Hodgkins Lymphoma).</brief_summary>
	<brief_title>A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas.</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma, Non-Hodgkin</mesh_term>
	<mesh_term>Lymphoma, B-Cell</mesh_term>
	<mesh_term>Lymphoma, Large B-Cell, Diffuse</mesh_term>
	<criteria>A diagnosis of recurrent or refractory Diffuse Bcell NonHodgkin's lymphoma. Adequate organ functions. Able to swallow capsules. More than 3 prior treatments for this disease. Serious heart problems.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>